NCT04452591Phase 3Active not recruiting

Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin

Study sponsor: CG Oncology, Inc. · CGON

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2030-06-16Estimated
Enrollment · participants190Estimated
Source updated2026-07-10Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Primary completion date changed

Before: 24 Dec 2027. After: 16 Jun 2030.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview